|
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, TACARYL to ZYPREXA
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS TACARYL to ZYPREXA Trade Name Generic TACARYL Methdilazine TACE Chlorotrianisene TAGAMET Cimetidine TALWIN *Pentazocine TAMBOCOR Flecainide TAMIFLU Oseltamivir TAPAZOLE Methimazole TASMAR Tolcapone TAVIST Clemastine TAXOL Paclitaxel TAZICEF Ceftazidime TAZIDIME Ceftazidime TEGISON Etretinate...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Dacarbazine to Etretinate
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Dacarbazine to Etretinate Generic Trade Name Dacarbazine DTIC-DOME Dactinomycin COSMEGEN Danazol DANOCRINE Dantrolene DANTRIUM Daunorubicin CERUBIDINE Deferoxamine DESFERAL Delavirdine RESCRIPTOR Demeclocycline DECLOMYCIN Desipramine NORPRAMIN, PERTOFRANE Desmopressin DDAVP, STIMATE Dexamethasone...
|
|
|
Etoposide - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Etoposide - [Medication] - Quest Diagnostics Patient Health Library Etoposide - [Medication] - Quest Diagnostics Patient Health Library Cancer, antineoplastic agents, antineoplastic chemotherapy, Cancer Chemotherapy, Chemotherapy, Chemotherapy Drugs, Lung...
|
|
|
Specificity Table TOX.xls page 28
author: Biosite Incorporated
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, TACARYL to ZYPREXA
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS TACARYL to ZYPREXA Trade Name Generic TACARYL Methdilazine TACE Chlorotrianisene TAGAMET Cimetidine TALWIN *Pentazocine TAMBOCOR Flecainide TAMIFLU Oseltamivir TAPAZOLE Methimazole TASMAR Tolcapone TAVIST Clemastine TAXOL Paclitaxel TAZICEF Ceftazidime TAZIDIME Ceftazidime TEGISON Etretinate...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Dacarbazine to Etretinate
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Dacarbazine to Etretinate Generic Trade Name Dacarbazine DTIC-DOME Dactinomycin COSMEGEN Danazol DANOCRINE Dantrolene DANTRIUM Daunorubicin CERUBIDINE Deferoxamine DESFERAL Delavirdine RESCRIPTOR Demeclocycline DECLOMYCIN Desipramine NORPRAMIN, PERTOFRANE Desmopressin DDAVP, STIMATE Dexamethasone...
|
|
|
rld_labeling_approved_apr_1999
Firm Date VEPESID Etoposide Capsule Etoposide Injection 19-557 18-768 S-023 S-041 Bristol 2-Apr-1999 NOLVADEX Tamoxifen Citrate Tablet 17-970 S-043 Zeneca Pharms 2-Apr-1999 ZOLADEX 3-MONTH Goserelin Acetate Implant 20-578 S-001 Zeneca Pharms 14-Apr-1999 CHILDREN'S MOTRIN ORAL SUSPENSION 40 MG/ML Ibuprofen Oral Suspension (Concentrated - Drops) 20-603 S-003 Mc Neil...
|
|
|
Prescription and OTC Drug Product List 9/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- ENDO PHARMS 400MG;5MG N40288 001 NOV 27, 1998 SEP CTEC -D- 400MG;7.5MG N40288 002 NOV 27, 1998 SEP CTEC -D- 400MG;10MG N40288 003 NOV 27, 1998 SEP CTEC -A- + 400MG;5MG N40288 001 NOV 27, 1998 SEP CTEC -A- + 400MG;10MG N40288 003 NOV 27, 1998 SEP CTEC -A- + 400MG;7.5MG...
|
|
|
Cyberbotanica: Podophyllotoxin
Pharmacology of Podophyllotoxin and Related Compounds [ Chemical Comparison Table | Mayapple Page ] Podophyllotoxin (podofilox) and its derivatives, etoposide and teniposide, are all cytostatic (antimitotic) glucosides
Etoposide and teniposide both block the cell cycle in two specific places: they block the phase between the last division and the start of DNA replication ...
|
|
|
Cancer Care Ontario Formulary
Information for patients, health professionals and public on cancer prevention, screening, treatment (radiation, chemotherapy, surgery), supportive care, research, education, and standards and guidelines ...
|
|
|
Textured/PwderFree Latex/2
® DESCRIPTION/ FEATURES LENGTH & THICKNESS BARRIER PROTECTION Average length (size medium glove) measured from the tip of the middle finger to the cuff
CHEMOTHERAPY DRUG PERMEATION cis- DiamineCarmustine dichloroplatinum Cyclophosphamide Dacarbazine Doxorubicin Hydrochloride (BCNU ® ) (Cisplatin) (CYTOXAN ® ) (DTIC- Dome ® ) (Adriamycin ® ) (3.3mg/ mL) (1...
author: Jan Kohn
|
|
|
Textured/PwderFree Latex/2 page 1
author: Jan Kohn
|
|
|
Prescription and OTC Drug Product List 1/1999
Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 1: January 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE BENDROFLUMETHIAZIDE; NADOLOL CAPSULE; ORAL TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN CORZIDE - ADD - AA MALLINCKRODT 500MG;5MG N88956 001 - ADD -...
|
|
|
FDA Drug Approvals List- April 1999
Original Application #: 050760 Approval Date: 15-APR-99 Trade Name: AMOXIL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SUSPENSION Applicant: SMITHKLINE BEECHAM PHARMACEUTICALS Active Ingredient(s): AMOXICILLIN OTC/RX Status: RX Indication(s):For the use of Amoxil for oral suspension 200mg/5mL and 400mg/5mL in divided doses q12h Original Application #: 020924 Approval Date:...
|
|
|
http://www.cancercare.on.ca/formulary/pdfmedicationinfo/Etoposide%20PO.pdf
For more information on this medication, please call your doctor or nurse, or the Cancer Centre Drug Information pharmacist. MEDICATION INFO SHEET ETOPOSIDE Capsules (e- TOE- poe- side) Other Names for this Medication: Vepesid (Brand Name) VP- 16 (Other Name) Appearance: Oral Capsules: Light ...
|
|
|
http://www.cancercare.on.ca/formulary/pdfmedicationinfo/Etoposide%20PO.pdf page 1
For more information on this medication, please call your doctor or nurse, or the Cancer Centre Drug Information pharmacist. MEDICATION INFO SHEET ETOPOSIDE Capsules (e- TOE- poe- side) Other Names for this Medication: Vepesid (Brand Name) VP- 16 (Other Name) Appearance: Oral Capsules: Light ...
|
|
|
http://www.cancercare.on.ca/formulary/pdfdrugs/Etoposi3.pdf
Etoposide CCO Formulary Revised March 2000 A DRUG NAME: ETOPOSIDE SYNONYM( S): VP- 16, VP- 16- 213, EPEG, demethylepipodophyllotoxin- ethylideneglucopyranoside, EPE, epipodophyllotoxin. COMMON TRADE NAME( S): Vepesid® (Brystol- Myers Squibb) B MECHANISM OF ACTION AND PHARMACOKINETICS ...
|
|
|
http://www.cancercare.on.ca/formulary/pdfdrugs/Etoposi3.pdf page 1
Etoposide CCO Formulary Revised March 2000 A DRUG NAME: ETOPOSIDE SYNONYM( S): VP- 16, VP- 16- 213, EPEG, demethylepipodophyllotoxin- ethylideneglucopyranoside, EPE, epipodophyllotoxin. COMMON TRADE NAME( S): Vepesid® (Brystol- Myers Squibb) B MECHANISM OF ACTION AND PHARMACOKINETICS ...
|
|
|
http://www.cancercare.on.ca/formulary/pdfdrugs/Etoposi.pdf
Etoposide CCO Formulary Revised March 2000 A DRUG NAME: ETOPOSIDE SYNONYM( S): VP- 16, VP- 16- 213, EPEG, demethylepipodophyllotoxin- ethylideneglucopyranoside, EPE, epipodophyllotoxin. COMMON TRADE NAME( S): Vepesid® (Brystol- Myers Squibb) B MECHANISM OF ACTION AND PHARMACOKINETICS ...
|
|
|
http://www.cancercare.on.ca/formulary/pdfdrugs/Etoposi.pdf page 1
Etoposide CCO Formulary Revised March 2000 A DRUG NAME: ETOPOSIDE SYNONYM( S): VP- 16, VP- 16- 213, EPEG, demethylepipodophyllotoxin- ethylideneglucopyranoside, EPE, epipodophyllotoxin. COMMON TRADE NAME( S): Vepesid® (Brystol- Myers Squibb) B MECHANISM OF ACTION AND PHARMACOKINETICS ...
|
|
|
http://www.fda.gov/cder/ogd/rld/18768s20.pdf page 4
|
|
|
http://www.fda.gov/cder/ogd/rld/18768s20.pdf page 3
|
|
|
ON3 outline v2
Final Outline INNOVATIONS IN ANTICANCER DRUGS III, 1995Ð 2002 Chapter 1: Executive Summary The Chemotherapy Market The Hormonal Market The New Immunotherapy Market Therapy Adjuvants and Novel Therapies Competitive Strategies Chapter 2: Introduction Scope of the Revised Study New Coverage ...
author: Dan
|
|
|
ON3 outline v2 page 3
Floxuridine Fludarabine Fluorouracil Leustatin Mercaptopurine Methotrexate Pentostatin Thioguanine Technical Advances in Antimetabolites Enhancement of Antimetabolites Thymidylate Synthase Inhibition GART Inhibition and AICART Inhibition Deoxycytidine Kinase New Antimetabolites ...
author: Dan
|
